Impact of intravenous immunoglobulin treatment on peripheral blood cells in children with Kawasaki disease complicated with coronary artery lesion

被引:0
|
作者
Zhao, Junshan [1 ]
Ma, Yingying [1 ]
Xin, Li [1 ]
Wang, Lijun [1 ]
Gao, Hongliang [1 ]
机构
[1] Hebei Childrens Hosp, Dept Intens Care Med Div 2, Shijiazhuang 050031, Peoples R China
关键词
Intravenous immunoglobulin; Coronary arteries; Kawasaki disease; Peripheral blood cells; MANAGEMENT;
D O I
10.1186/s13052-025-01891-2
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
BackgroundKawasaki disease (KD) primarily affects young children and can lead to coronary artery lesions. Intravenous immunoglobulin (IVIG) treatment is essential; however, it may fail in 10-20% of cases, increasing the risk of complications. Complete blood count (CBC) tests can help assess disease severity and predict risks. This study investigated the impact of IVIG on peripheral blood cells, including neutrophil count, platelet-lymphocyte ratio, hemoglobin level, mean platelet volume (MPV), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP), in children with KD complicated by coronary artery lesions (CALs). MethodsThis retrospective analysis included children diagnosed with typical KD. The neutrophil count, hemoglobin level, platelet-lymphocyte ratio, MPV, ESR, and CRP were compared between those with (CAL+) and without (CAL-) CALs during the acute phase, as well as at 7 days, 1 month, and 2 months after normalizing body temperature with IVIG. ResultsA total of 76 children with KD were analyzed, including 30 with CAL+. CAL+ and CAL- patients exhibited elevated neutrophil counts during the acute phase, with no significant differences (P > 0.05) between groups. After IVIG treatment, CAL- patients demonstrated a more pronounced reduction in neutrophil count (P < 0.05) than CAL+ patients. Hemoglobin levels differed significantly during the acute phase (P < 0.05) but were comparable post-treatment (P > 0.05) between CAL+ and CAL- patients. The platelet-lymphocyte ratio varied significantly between groups during the acute phase and 1-month post-treatment (P < 0.05). Mean ESR and CRP levels were significantly elevated at all time points in the CAL+ group compared with the CAL- group. No significant differences in MPV were observed between groups. ConclusionsAfter IVIG treatment, CAL- patients demonstrated a more important reduction in neutrophil count than CAL+ patients after IVIG. Pediatric patients with KD and CAL+ showed lower hemoglobin and platelet-lymphocyte ratio and higher ESR and CRP compared with CAL-, suggesting that they may serve as indicators for CAL in pediatric patients with KD.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Infantile Kawasaki disease: High incidence of coronary artery aneurysms in spite of appropriate intravenous immunoglobulin treatment
    Akagi, T
    Himeno, W
    Ishii, M
    Kato, H
    Matsuishi, T
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 394A - 394A
  • [22] Intravenous Methylprednisolone Pulse Therapy Versus Intravenous Immunoglobulin in the Prevention of Coronary Artery Disease in Children with Kawasaki Disease: A Randomized Controlled Trial
    Aslani, Nahid
    Raeeskarami, Seyed-Reza
    Aghaei-Moghadam, Ehsan
    Tahghighi, Fatemeh
    Assari, Raheleh
    Sadeghi, Payman
    Ziaee, Vahid
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [23] Analysis of Risk Factors for Coronary Artery Lesion in Children with Kawasaki Disease
    Bai, Bing
    Ya, Jin-liang
    Yan, Chao
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (08): : 1037 - 1041
  • [24] Resistance to intravenous immunoglobulin in children with Kawasaki disease
    Tremoulet, Adriana H.
    Best, Brookie M.
    Song, Sungchan
    Wang, Susan
    Corinaldesi, Elena
    Eichenfield, Julia R.
    Martin, Danielle D.
    Newburger, Jane W.
    Burns, Jane C.
    JOURNAL OF PEDIATRICS, 2008, 153 (01): : 117 - 121
  • [25] Non-Responders to Intravenous Immunoglobulin and Coronary Artery Dilatation in Kawasaki Disease: Predictive Parameters in Korean Children
    Kim, Bo Young
    Kim, Dongwan
    Kim, Yong Hyun
    Ryoo, Eell
    Sun, Yong Han
    Jeon, In-sang
    Jung, Mi-Jin
    Cho, Hye Kyung
    Tchah, Hann
    Choi, Deok Young
    Kim, Na Yeon
    KOREAN CIRCULATION JOURNAL, 2016, 46 (04) : 542 - 549
  • [26] Is there an association between intravenous immunoglobulin resistance and coronary artery lesion in Kawasaki disease?-Current evidence based on a meta-analysis
    Zheng, Xiaolan
    Li, Jinhui
    Yue, Peng
    Liu, Lei
    Li, Jiawen
    Zhou, Kaiyu
    Hua, Yimin
    Li, Yifei
    PLOS ONE, 2021, 16 (03):
  • [27] Role of intravenous immunoglobulin in the treatment of Kawasaki disease
    Lo, Mindy S.
    Newburger, Jane W.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2018, 21 (01) : 64 - 69
  • [28] The Effect of Intravenous Immunoglobulin on Inhibiting Peripheral Blood Lymphocyte Apoptosis in Acute Kawasaki Disease
    Qijian Yi
    Chengrong Li
    Xiqiang Yang
    Pediatric Research, 2003, 53 (1) : 170 - 170
  • [29] The effect of intravenous immunoglobulin on inhibiting peripheral blood lymphocyte apoptosis in acute Kawasaki disease
    Yi, QJ
    Li, CR
    Yang, XQ
    PEDIATRIC RESEARCH, 2003, 53 (01) : 170 - 170
  • [30] Effect of intravenous immunoglobulin on inhibiting peripheral blood lymphocyte apoptosis in acute Kawasaki disease
    Yi, QJ
    Li, CR
    Yang, XQ
    ACTA PAEDIATRICA, 2001, 90 (06) : 623 - 627